Medicinal cannabis company wants referendum delayed – New Zealand Doctor Online

Your patient with type 2 diabetes is not reaching HbA1c target after lifestyle changes and treatment with metformin. So what next? Dr Rick Cutfield takes an expert look at the second-line treatment options available in New Zealand, including newly funded DPP-4 inhibitor vildagliptin.

Source: https://www.nzdoctor.co.nz/article/news/medicinal-cannabis-company-wants-referendum-delayed